Gastric Electrical Stimulators Market to Reach US$ 454.7 Mn by 2033 at 5.7% CAGR | Persistence Market Research

The global gastric electrical stimulators market is expected to grow significantly over the next few years, from an estimated value of US$ 276.8 million in 2026 to US$ 454.7 million by 2033, achieving a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2026 to 2033. Gastric electrical stimulators (GES) are primarily used in treating gastric motility disorders like gastroparesis, particularly in patients who have not responded well to traditional pharmacological treatments. This market is being fueled by several factors, including the increasing prevalence of diabetes, obesity, and gastrointestinal diseases.

Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/25954

Key Drivers

The growing global incidence of gastroparesis and other gastric motility disorders, especially in patients with diabetes, neurological disorders, or those recovering from surgery, is one of the primary factors contributing to the market's expansion. As the number of individuals suffering from these chronic conditions rises, the demand for effective, non-pharmacological treatments like gastric electrical stimulators continues to increase.

Moreover, the shift from conventional drug-based treatments to device-based neuromodulation therapies is evident. Unlike pharmacological therapies, gastric electrical stimulators offer long-term symptom management with fewer side effects. This shift is accelerating the adoption of these devices, particularly in hospital and specialty clinic settings.

Advancements in Technology

Technological advancements play a significant role in the market's growth. Improvements in implantable device design, stimulation algorithms, battery longevity, and personalized therapy are making gastric electrical stimulators more effective and easier for patients to manage. These innovations are contributing to better clinical outcomes and improving the overall quality of life for patients.

Regional Analysis

The global market for gastric electrical stimulators is segmented by region, with North America, Europe, and Asia Pacific showing the most significant growth prospects.

North America

North America holds the largest market share, accounting for 47.3% of the global market in 2026. This is mainly due to the region's advanced healthcare infrastructure, a high incidence of diabetes-related gastroparesis, and increasing physician awareness. Additionally, favorable reimbursement policies in countries like the United States support the adoption of these devices. North America also benefits from the presence of leading manufacturers and ongoing clinical trials that drive product innovation and clinical validation.

Asia Pacific

Asia Pacific is the fastest-growing region, with a projected CAGR of 7.5% between 2026 and 2033. Countries like China, India, Japan, and South Korea are experiencing a rise in diabetes, obesity, and gastrointestinal disorders, which is increasing the demand for gastric electrical stimulators. Improving healthcare infrastructure, rising patient awareness, and the expansion of private hospitals and specialty clinics in these regions are expected to drive market growth.

Get Custom Insights Designed for Your Businecss: https://www.persistencemarketresearch.com/request-customization/25954

Europe

In Europe, countries like Germany, the UK, France, and Italy are expected to see steady growth due to an aging population and increasing diagnoses of gastrointestinal motility disorders. The public healthcare systems in Europe ensure that patients have access to advanced diagnostic and treatment options, which is contributing to the adoption of gastric electrical stimulators.

Market Dynamics

Drivers

Rising Incidence of Gastroparesis: The increasing prevalence of gastroparesis, particularly in diabetic and neurological patients, continues to be the leading driver of market growth. With drug therapies offering limited relief, more patients are turning to gastric electrical stimulation as a long-term treatment option.

Technological Advancements: Improvements in stimulation precision, battery longevity, and programmability of gastric electrical stimulators are enhancing patient outcomes and contributing to market expansion. These innovations also make the treatment process more convenient and cost-effective.

Shift Towards Device-Based Therapies: As healthcare providers shift away from traditional drug therapies to more advanced device-based neuromodulation therapies, the adoption of gastric electrical stimulators is expected to grow.

Restraints

High Treatment Costs: One of the major barriers to market growth is the high cost of gastric electrical stimulation therapy, which includes the device price, surgical implantation, and long-term monitoring. This is a significant hurdle, especially in emerging economies where access to advanced healthcare is limited.

Limited Awareness: There is a lack of awareness among general practitioners and non-specialist clinicians about gastroparesis and the potential benefits of gastric electrical stimulators. This limits the referral rates for advanced treatments and delays the diagnosis of eligible patients.

Opportunities

Expansion in Emerging Markets: The market for gastric electrical stimulators presents significant growth opportunities in Asia Pacific, Latin America, and the Middle East. With rising rates of diabetes, obesity, and gastrointestinal diseases, these regions represent untapped potential.

Technological Innovation: The development of next-generation gastric electrical stimulators with longer battery life, smaller form factors, and more minimally invasive implantation techniques will drive further market growth. Additionally, integrating remote monitoring platforms can improve long-term disease management.

Get Custom Insights Designed for Your Businecss: https://www.persistencemarketresearch.com/request-customization/25954

Market Segmentation

By Product

High Frequency
Low Frequency

By Application

Gastroparesis
Obesity
Chronic Nausea
Others

By End-user

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

Competitive Landscape

The gastric electrical stimulators market is highly competitive, with major players such as Medtronic, Philips, Enterra Medical, IntraPace, and ReShape Lifesciences at the forefront. These companies are focused on advancing technology, expanding their product portfolios, and ensuring regulatory compliance to maintain market leadership.

In recent developments:

Enterra Medical launched the Enterra ReliaStim in January 2026, a next-generation stimulation lead designed to enhance the precision of gastric electrical stimulation. This advancement underscores the company's commitment to innovation.

Good Samaritan Medical Center held events in April 2025 to raise awareness for Gastroparesis Awareness Month, focusing on treatment options like gastric electrical stimulation for improving patients' quality of life.

Conclusion

The gastric electrical stimulators market is poised for significant growth in the coming years, driven by increasing prevalence of gastroparesis, obesity, and diabetes, along with continued advancements in technology. As the demand for non-pharmacological treatments rises, the market will likely see wider adoption across hospitals and specialty clinics, particularly as new technological innovations and affordable access become more widespread.

The future of this market lies in overcoming the challenges of high treatment costs and expanding access in emerging regions, while also capitalizing on innovations that improve patient outcomes and overall treatment efficiency. With these factors in mind, the gastric electrical stimulators market is on track for steady and sustained growth over the next decade.

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.